Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Pediatr Blood Cancer ; 63(9): 1653-6, 2016 09.
Article in English | MEDLINE | ID: mdl-27163649

ABSTRACT

Humoral and cellular immunity were studied in 28 children completing conventional treatment of standard-risk (SR) or intermediate-risk (IR) acute lymphoblastic leukemia (ALL). Both naïve and memory B cells were most severely affected and showed slow recovery during the 2-year follow-up, while the T-cell compartment showed only minor changes. Immunoglobulins and IgG subclasses, components, and antibodies against vaccine-preventable diseases were not significantly affected. In conclusion, immune recovery after conventional chemotherapy for SR and IR ALL is marked by B-cell depletion, but otherwise did not show any severe deficiencies in lymphocyte function.


Subject(s)
B-Lymphocytes/immunology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Adolescent , Adult , Child , Child, Preschool , Complement Pathway, Alternative , Humans , Immunity, Humoral , Precursor Cell Lymphoblastic Leukemia-Lymphoma/immunology
SELECTION OF CITATIONS
SEARCH DETAIL